Basic Feldene Information

• INN (International Nonproprietary Name): Piroxicam.
• Brand Names Available In United Kingdom: Feldene (capsules 10 mg, 20 mg), with Feldene listed in pharmacies as "Feldene Caps".
• ATC Code: M01AC01.
• Forms & Dosages: Capsules 10 mg and 20 mg; tablets 10 mg and 20 mg; dispersible tablets 20 mg; gel/cream formulations 0.5%–1% in some markets.
• Manufacturers In United Kingdom: Pfizer, Sandoz, Hexal, Teva, Mylan (leading international suppliers noted in product information).
• Registration Status In United Kingdom: Registered as a prescription medicine with the MHRA.
• OTC / Rx Classification: Prescription-only (Rx) in all reviewed jurisdictions.

Latest Research Highlights (UK & EU 2022–2024)

Clinicians ask whether feldene still has a role for chronic arthritis pain.

Recent UK and EU observational studies and SmPC reviews (2022–2024) reiterate piroxicam’s efficacy for chronic musculoskeletal pain while emphasising safety vigilance because of its long half-life and accumulation risk.

Studies reported comparable analgesia to other long-acting NSAIDs for osteoarthritis and rheumatoid arthritis with typical dosing of 20 mg once daily.

Higher gastrointestinal risk was observed versus short-acting NSAIDs in older cohorts, and cardiovascular monitoring signals were noted in patients with cardiac comorbidity.

Half-life data remain relevant: Half-life: ~50 hours supports once-daily dosing but increases accumulation risk.

Trial endpoints (definition):

• Pain Score: Change in validated pain rating scales over 4–12 weeks.
• Function: Improvement in mobility or daily activities scales.
• Adverse Event Rate: Incidence of GI, CV or renal adverse events during follow-up.

Regulatory summaries from the MHRA and the EMA through 2024 continue to emphasise prescription-only status and periodic review of long-term NSAID use.

Clinical Effectiveness In The UK

Patients commonly ask, "Will feldene help my arthritis?"

NHS practice finds piroxicam effective for symptomatic relief in osteoarthritis and rheumatoid arthritis when given at 20 mg once daily or lower.

Some patients respond to 10 mg daily, and clinicians sometimes split doses into 2 × 10 mg to reduce GI disturbance.

Real-world audits reported patient-reported outcome improvements in pain and function over 4–12 weeks.

Long half-life increases duration of adverse effects if intolerance occurs, so clinicians weigh benefit against safety.

• Patient-Reported Improvements: Reduced pain scores and better function within 4–12 weeks.
• Monitoring Balance: GI and renal risk assessments are routine in primary care and rheumatology clinics.
• Co-Prescription: Proton pump inhibitors are commonly used for gastroprotection in high-risk patients.

Small data highlight: local audits suggest a modest number needed to treat in symptomatic responders but a measurable number needed to harm for GI events in elderly groups.

Patient portal comments (NHS App, Patient.info) reflect relief for some patients but concerns about long-term safety and monitoring.

Indications And Expanded Uses (MHRA & NHS Practice)

What Is Feldene Licensed For?

• Authorised Indications: Use in rheumatic diseases, pain and inflammation of musculoskeletal origin (ATC Code M01AC01).
• Contested/Conditional Uses: Chronic therapy requires periodic review due to safety profile and long half-life.
• Off-Label Examples: Acute gout flares, ankylosing spondylitis and selected post-operative pain — used occasionally under consultant direction with documented consent and monitoring.

Duration Note: Chronic use is reviewed every 2–3 months as standard practice.

Prescribing Outside Licensed Indications Must Be Documented.

Obtain and record patient consent and monitoring plans when using off-label.

Composition And Brand Landscape In The UK

Which formulations will a customer see on the shelf or online?

Active Ingredient: Piroxicam (INN).

UK Brands And Generics Include Feldene (original) and multiple generics supplied by major manufacturers.

Prolonged‑release formulations are available in some EU markets and may affect GI profile.

Mention On Labels: "Feldene Caps" and "piroxicam 20 mg" are common pharmacy labelling terms.

MHRA-Registered Product: Remains prescription-only in the UK.

Contraindications And Special Precautions

Who must not take feldene?

• Absolute Contraindications: Known hypersensitivity to piroxicam or NSAIDs.
• Absolute Contraindications: Active peptic ulcer or GI bleeding history.
• Absolute Contraindications: Severe heart failure, severe hepatic or renal impairment.
• Absolute Contraindications: Use after CABG (coronary artery bypass graft).
• Absolute Contraindications: Pregnancy, especially third trimester.

• Relative Contraindications Requiring Monitoring: Elderly patients.
• Relative Contraindications Requiring Monitoring: History of ulcers or GI disease.
• Relative Contraindications Requiring Monitoring: Hypertension or cardiac disease.
• Relative Contraindications Requiring Monitoring: Concomitant anticoagulants, antiplatelets or corticosteroids.
• Relative Contraindications Requiring Monitoring: Mild–moderate renal or hepatic dysfunction.

Practical Counselling Points:

• Avoid excess alcohol as it increases GI bleeding risk.
• Driving And Machinery: Piroxicam can cause dizziness or drowsiness; advise caution.
• Monitoring: Regular blood pressure, renal and hepatic function checks are recommended.

Prescriber Decision Flow (primary care):

1. Assess comorbidities and concurrent medicines.
2. If high GI or renal risk, consider alternative or add PPI gastroprotection.
3. Start lowest effective dose and review at 4–8 weeks; then every 2–3 months for chronic therapy.

Dosage Guidelines (NHS-Aligned)

How should feldene be dosed safely?

Elderly: Start at the lowest effective dose and monitor closely for GI, renal and cardiovascular effects.

Renal/Liver Impairment: Avoid or use caution and monitor regularly due to prolonged elimination.

Children: Not generally recommended; safety and efficacy not established for paediatric use.

Missed Dose: Take as soon as remembered unless it is almost time for the next dose; do not double up.

Overdose: Seek urgent medical attention; symptoms include nausea, vomiting, GI bleeding or severe CNS effects.

Checklist For Dose Adjustments:

• Consider age, weight and comorbidity.
• Review interacting drugs before starting.
• Plan monitoring intervals at baseline, 4–8 weeks and then 2–3 monthly if continued.

Interactions Overview

Which medicines increase risk when taken with feldene?

Food and Drink: Alcohol increases GI bleeding risk; caffeine has no clinically significant interaction but may mask pain.

MHRA Yellow Card Reports: GI bleeding and renal impairment are commonly reported with long-acting NSAIDs.

Clinical Action: Review medication lists at every consultation and use pharmacist-led reconciliation when possible.

Cultural Perceptions And Patient Habits In The UK

What do UK patients worry about when prescribed feldene?

Many patients trust NHS advice and pharmacist counselling when considering long-term NSAIDs.

Common online discussion points (Patient.info, Mumsnet, NHS forums) include GI risk, long-term safety and preference for OTC ibuprofen for short-term use.

Pharmacists in high-street chains and independents act as gatekeepers and provide counselling on drug interactions and monitoring.

Patients routinely consult the NHS app and NHS.uk for SmPC summaries before accepting long-term NSAID therapy.

• Patient Concerns: GI safety, interactions, cost and need for monitoring.
• Information Sources: Pharmacist, GP, NHS App, online forums.

Culturally, primary care favours conservative trial durations and PPI co-prescription for at-risk patients.

Availability And Pricing Patterns (UK Regions & Channels)

How do patients obtain feldene in the UK and what affects cost?

Piroxicam (Feldene and generics) is prescription-only in the UK.

Availability: Stocked by Boots, LloydsPharmacy, independent pharmacies and online pharmacies that require a valid e-prescription.

Regional Differences: Prescriptions are free in Scotland, Wales and Northern Ireland, while England has a per-item NHS charge which can affect whether patients request private purchase or repeats.

Electronic prescribing and NHS repeat dispensing alter dispensing frequency and cost burden for patients.

Packaging Options: 10 mg and 20 mg capsules and dispersible forms; topical gel availability varies by supplier.

In our online pharmacy, feldene is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.

Comparable Medicines And Prescribing Preferences

When should a GP choose feldene over another NSAID?

• Pros For Piroxicam: Once-daily, long-acting analgesia suitable for chronic symptoms.
• Cons For Piroxicam: Prolonged adverse-event duration if intolerance occurs and higher GI risk in older patients.
• Meloxicam May Be Preferred Where Lower GI Risk Is A Priority.
• Ibuprofen Is Often Used For Short-Term, Acute Pain Scenarios.

Prescribing choices in NHS primary care reflect comorbidity profile, patient age, GI/CV risk and cost.

FAQ

• Is Feldene Available On NHS Prescriptions? — Yes; piroxicam is prescription-only and may be prescribed where clinically indicated.
• Can I Take Feldene Long-Term? — Only with ongoing review, typically every 2–3 months, and monitoring of BP, renal and hepatic function.
• What If I Miss A Dose Or Overdose? — Missed: take when remembered unless near the next dose; do not double. Overdose: seek urgent medical help — symptoms include nausea, vomiting, GI bleeding and drowsiness.
• Can I Drink Alcohol While Taking It? — Avoid excess alcohol because it increases GI bleeding risk.

Further reading and SmPC details are available on the MHRA and EMA websites referenced earlier.

Guidelines For Proper Use (Pharmacist Counselling & NHS Support)

What should a pharmacist cover when dispensing feldene?

• Confirm Indication And Comorbidities Before Supply.
• Review All Medicines For Interactions, Especially Anticoagulants, ACEi/ARBs And Diuretics.
• Discuss GI Risk And Signs Of Bleeding With The Patient.
• Advise About Driving And Working If Drowsy Or Dizzy.
• Review Alcohol Intake And Recommend Limiting Consumption.
• Recommend Co-Prescription Of A PPI For High-Risk Patients.

Monitoring Schedule (Practical Flow):

1. Start: Baseline BP, renal and liver function tests.
2. Review At 4–8 Weeks For Efficacy And Tolerability.
3. For Chronic Therapy: Review Every 2–3 Months.

Patient-Facing Leaflet Template (Short):

• Why You Are Taking This Medicine And How To Take It.
• Common Side Effects And When To Seek Help.
• Interactions To Watch For And Medicines To Avoid.
• Plan For Tests And Follow-Up Appointments.

Document Informed Consent For Off-Label Use And Offer Pharmacist Follow-Up Calls In The First 2 Weeks.

Delivery Across United Kingdom